Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Terns Pharmaceuticals (TERN) Equity Ratio (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Equity Ratio readings, the most recent being 0.98 for Q4 2025.

  • Quarterly Equity Ratio rose 3.32% to 0.98 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.98 through Dec 2025, up 3.32% year-over-year, with the annual reading at 0.98 for FY2025, 3.32% up from the prior year.
  • Equity Ratio hit 0.98 in Q4 2025 for Terns Pharmaceuticals, up from 0.94 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.98 in Q4 2025 and bottomed at 0.94 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.96, with a median of 0.95 recorded in 2021.
  • The largest annual shift saw Equity Ratio surged 174.95% in 2021 before it dropped 2.27% in 2025.
  • Terns Pharmaceuticals' Equity Ratio stood at 0.95 in 2021, then grew by 1.16% to 0.96 in 2022, then dropped by 1.43% to 0.95 in 2023, then decreased by 0.07% to 0.95 in 2024, then increased by 3.32% to 0.98 in 2025.
  • Per Business Quant, the three most recent readings for TERN's Equity Ratio are 0.98 (Q4 2025), 0.94 (Q3 2025), and 0.95 (Q2 2025).